Global Cord Blood (CORBF) Competitors $1.50 +0.45 (+42.86%) (As of 12/20/2024 04:34 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsTrends CORBF vs. ACONW, AONC, DHACW, LFMDP, OTRKP, PIIIW, TALKW, TOIIW, NTRA, and FMSShould you be buying Global Cord Blood stock or one of its competitors? The main competitors of Global Cord Blood include Aclarion (ACONW), American Oncology Network (AONC), Digital Health Acquisition (DHACW), LifeMD (LFMDP), Ontrak (OTRKP), P3 Health Partners (PIIIW), Talkspace (TALKW), Oncology Institute (TOIIW), Natera (NTRA), and Fresenius Medical Care (FMS). These companies are all part of the "healthcare" industry. Global Cord Blood vs. Aclarion American Oncology Network Digital Health Acquisition LifeMD Ontrak P3 Health Partners Talkspace Oncology Institute Natera Fresenius Medical Care Aclarion (NASDAQ:ACONW) and Global Cord Blood (NYSE:CORBF) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their community ranking, valuation, institutional ownership, analyst recommendations, dividends, earnings, profitability, risk and media sentiment. Which has stronger earnings & valuation, ACONW or CORBF? Global Cord Blood has higher revenue and earnings than Aclarion. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAclarion$49.29KN/AN/AN/AN/AGlobal Cord Blood$196.12M0.93$79.04MN/AN/A Is ACONW or CORBF more profitable? Company Net Margins Return on Equity Return on Assets AclarionN/A N/A N/A Global Cord Blood N/A N/A N/A Does the MarketBeat Community believe in ACONW or CORBF? Aclarion and Global Cord Blood both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformAclarionN/AN/AGlobal Cord BloodN/AN/A Does the media refer more to ACONW or CORBF? In the previous week, Aclarion's average media sentiment score of 0.00 equaled Global Cord Blood'saverage media sentiment score. Company Overall Sentiment Aclarion Neutral Global Cord Blood Neutral SummaryGlobal Cord Blood beats Aclarion on 1 of the 1 factors compared between the two stocks. Ad Behind the MarketsWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this window of opportunity is closing fast.Click here for the ticker >>> Get Global Cord Blood News Delivered to You Automatically Sign up to receive the latest news and ratings for CORBF and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CORBF vs. The Competition Export to ExcelMetricGlobal Cord Bloodhealth & allied services, not elsewhere classified IndustryMedical SectorNYSE ExchangeMarket Cap$182.33M$1.91B$5.14B$19.19BDividend YieldN/A7.04%5.09%3.62%P/E RatioN/A14.1589.7441.30Price / Sales0.933.191,117.0917.58Price / Cash1.779.7743.1021.28Price / BookN/A3.044.785.32Net Income$79.04M$69.56M$120.31M$989.88M7 Day PerformanceN/A-1.73%-1.92%-3.54%1 Month Performance20.00%-4.93%13.65%-4.73%1 Year Performance23.97%-23.01%28.34%11.57% Global Cord Blood Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CORBFGlobal Cord BloodN/A$1.50+42.9%N/A+15.4%$182.33M$196.12M0.001,202ACONWAclarionN/A$0.04flatN/A-36.1%$0.00$49,289.000.007Positive NewsAONCAmerican Oncology NetworkN/A$4.68+2.7%N/A-22.5%$0.00$1.34B0.001,520News CoverageDHACWDigital Health AcquisitionN/A$0.06flatN/AN/A$0.00N/A0.00N/ALFMDPLifeMDN/A$22.16-1.6%N/A+17.1%$0.00$193.06M0.00230OTRKPOntrakN/A$0.28-3.5%N/A-57.6%$0.00$10.84M0.00250Gap DownPIIIWP3 Health PartnersN/A$0.01-1.2%N/AN/A$0.00$1.48B0.00500Positive NewsTALKWTalkspaceN/A$0.13-2.2%N/A+7.1%$0.00$181.29M0.00500Gap DownTOIIWOncology InstituteN/A$0.01-1.0%N/A-95.0%$0.00$378.93M0.00660Positive NewsNTRANatera2.0775 of 5 stars$167.04+0.3%$152.67-8.6%+168.5%$22.05B$1.53B-94.633,293Positive NewsGap DownFMSFresenius Medical Care3.4964 of 5 stars$23.92+1.1%$24.30+1.6%+8.6%$14.04B$19.24B19.791,358News CoveragePositive News Related Companies and Tools Related Companies ACONW Competitors AONC Competitors DHACW Competitors LFMDP Competitors OTRKP Competitors PIIIW Competitors TALKW Competitors TOIIW Competitors NTRA Competitors FMS Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:CORBF) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredMUST SEE: The most important video in the world right now?If you have a significant amount of money in the stock market right now — or if you're sitting on the sideline...InvestorPlace | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global Cord Blood Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Global Cord Blood With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CORBF Stock Alerts